Israel Englander’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-40,509
| Closed | -$3.9M | – | 6120 |
|
|
2026
Q1 | $3.9M | Buy |
40,509
+37,307
| +1,165% | +$3.73M | ﹤0.01% | 3221 |
|
|
2025
Q4 | $311K | Sell |
3,202
-94,982
| -97% | -$8.15M | ﹤0.01% | 5243 |
|
|
2025
Q3 | $6.99M | Sell |
98,184
-13,444
| -12% | -$896K | ﹤0.01% | 2763 |
|
|
2025
Q2 | $6.67M | Buy |
111,628
+41,481
| +59% | +$2.27M | ﹤0.01% | 2688 |
|
|
2025
Q1 | $3.68M | Buy |
70,147
+26,096
| +59% | +$1.47M | ﹤0.01% | 3169 |
|
|
2024
Q4 | $2.42M | Sell |
44,051
-36,176
| -45% | -$1.9M | ﹤0.01% | 3474 |
|
|
2024
Q3 | $4.03M | Sell |
80,227
-2,827
| -3% | -$130K | ﹤0.01% | 3037 |
|
|
2024
Q2 | $3.65M | Sell |
83,054
-14,045
| -14% | -$597K | ﹤0.01% | 3018 |
|
|
2024
Q1 | $4.27M | Sell |
97,099
-5,657
| -6% | -$250K | ﹤0.01% | 3024 |
|
|
2023
Q4 | $4.88M | Buy |
102,756
+15,577
| +18% | +$655K | ﹤0.01% | 2812 |
|
|
2023
Q3 | $3.87M | Buy |
87,179
+31,876
| +58% | +$1.48M | ﹤0.01% | 2954 |
|
|
2023
Q2 | $2.64M | Buy |
55,303
+9,469
| +21% | +$427K | ﹤0.01% | 3237 |
|
|
2023
Q1 | $1.8M | Sell |
45,834
-13,510
| -23% | -$491K | ﹤0.01% | 3545 |
|
|
2022
Q4 | $1.68M | Buy |
59,344
+43,507
| +275% | +$1.24M | ﹤0.01% | 3712 |
|
|
2022
Q3 | $476K | Sell |
15,837
-19,117
| -55% | -$666K | ﹤0.01% | 5014 |
|
|
2022
Q2 | $1.19M | Buy |
34,954
+3,238
| +10% | +$116K | ﹤0.01% | 4215 |
|
|
2022
Q1 | $1.42M | Buy |
+31,716
| New | +$1.47M | ﹤0.01% | 4177 |
|
|
2021
Q4 | – | Sell |
-11,241
| Closed | -$378K | – | 7094 |
|
|
2021
Q3 | $378K | Buy |
+11,241
| New | +$382K | ﹤0.01% | 5616 |
|
|
2020
Q2 | – | Sell |
-58,561
| Closed | -$1.25M | – | 4375 |
|
|
2020
Q1 | $1.25M | Buy |
58,561
+10,856
| +23% | +$259K | ﹤0.01% | 2327 |
|
|
2019
Q4 | $1.11M | Buy |
47,705
+26,250
| +122% | +$613K | ﹤0.01% | 2955 |
|
|
2019
Q3 | $450K | Buy |
+21,455
| New | +$438K | ﹤0.01% | 3328 |
|
|
2017
Q1 | – | Sell |
-24,557
| Closed | -$273K | – | 3661 |
|
|
2016
Q4 | $273K | Sell |
24,557
-29,518
| -55% | -$318K | ﹤0.01% | 2946 |
|
|
2016
Q3 | $919K | Buy |
54,075
+28,856
| +114% | +$534K | ﹤0.01% | 2313 |
|
|
2016
Q2 | $549K | Buy |
25,219
+4,919
| +24% | +$88.5K | ﹤0.01% | 2446 |
|
|
2016
Q1 | $389K | Buy |
20,300
+4,128
| +26% | +$79K | ﹤0.01% | 2644 |
|
|
2015
Q4 | $453K | Buy |
+16,172
| New | +$457K | ﹤0.01% | 2696 |
|
Other funds holding IRMD
CCM
NTCM
Israel Englander's IRMD Position: Q2 2026 in Review
Israel Englander sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 40,509 shares — an estimated $3.9M sold.
Israel Englander first reported a position in IRMD in Q4 2015 and held it in 26 quarters. The position peaked at $6.99M in Q3 2025. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Israel Englander reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 40,509 iRadimed shares in Q2 2026, an estimated $3.9M.
- Israel Englander first reported a position in iRadimed in Q4 2015 and held it in 26 quarters.
- Israel Englander's iRadimed position peaked at $6.99M in Q3 2025.
- 212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.